List of Tables
Table 1. Global PCSK9-targeted Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Subcutaneous Injection
Table 3. Key Players of Oral
Table 4. Global PCSK9-targeted Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global PCSK9-targeted Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global PCSK9-targeted Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global PCSK9-targeted Therapy Market Share by Region (2020-2025)
Table 8. Global PCSK9-targeted Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global PCSK9-targeted Therapy Market Share by Region (2026-2031)
Table 10. PCSK9-targeted Therapy Market Trends
Table 11. PCSK9-targeted Therapy Market Drivers
Table 12. PCSK9-targeted Therapy Market Challenges
Table 13. PCSK9-targeted Therapy Market Restraints
Table 14. Global PCSK9-targeted Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global PCSK9-targeted Therapy Market Share by Players (2020-2025)
Table 16. Global Top PCSK9-targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCSK9-targeted Therapy as of 2024)
Table 17. Ranking of Global Top PCSK9-targeted Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by PCSK9-targeted Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of PCSK9-targeted Therapy, Headquarters and Area Served
Table 20. Global Key Players of PCSK9-targeted Therapy, Product and Application
Table 21. Global Key Players of PCSK9-targeted Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global PCSK9-targeted Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global PCSK9-targeted Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global PCSK9-targeted Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global PCSK9-targeted Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global PCSK9-targeted Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global PCSK9-targeted Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global PCSK9-targeted Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global PCSK9-targeted Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America PCSK9-targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America PCSK9-targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America PCSK9-targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe PCSK9-targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe PCSK9-targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe PCSK9-targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific PCSK9-targeted Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific PCSK9-targeted Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific PCSK9-targeted Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America PCSK9-targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America PCSK9-targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America PCSK9-targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa PCSK9-targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa PCSK9-targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa PCSK9-targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Novo Nordisk Company Details
Table 47. Novo Nordisk Business Overview
Table 48. Novo Nordisk PCSK9-targeted Therapy Product
Table 49. Novo Nordisk Revenue in PCSK9-targeted Therapy Business (2020-2025) & (US$ Million)
Table 50. Novo Nordisk Recent Development
Table 51. Sanofi Company Details
Table 52. Sanofi Business Overview
Table 53. Sanofi PCSK9-targeted Therapy Product
Table 54. Sanofi Revenue in PCSK9-targeted Therapy Business (2020-2025) & (US$ Million)
Table 55. Sanofi Recent Development
Table 56. Regeneron Company Details
Table 57. Regeneron Business Overview
Table 58. Regeneron PCSK9-targeted Therapy Product
Table 59. Regeneron Revenue in PCSK9-targeted Therapy Business (2020-2025) & (US$ Million)
Table 60. Regeneron Recent Development
Table 61. Amgen Company Details
Table 62. Amgen Business Overview
Table 63. Amgen PCSK9-targeted Therapy Product
Table 64. Amgen Revenue in PCSK9-targeted Therapy Business (2020-2025) & (US$ Million)
Table 65. Amgen Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis PCSK9-targeted Therapy Product
Table 69. Novartis Revenue in PCSK9-targeted Therapy Business (2020-2025) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Hengrui Pharma Company Details
Table 72. Hengrui Pharma Business Overview
Table 73. Hengrui Pharma PCSK9-targeted Therapy Product
Table 74. Hengrui Pharma Revenue in PCSK9-targeted Therapy Business (2020-2025) & (US$ Million)
Table 75. Hengrui Pharma Recent Development
Table 76. TopAlliance Biosciences Company Details
Table 77. TopAlliance Biosciences Business Overview
Table 78. TopAlliance Biosciences PCSK9-targeted Therapy Product
Table 79. TopAlliance Biosciences Revenue in PCSK9-targeted Therapy Business (2020-2025) & (US$ Million)
Table 80. TopAlliance Biosciences Recent Development
Table 81. Innovent Biologics, Inc. Company Details
Table 82. Innovent Biologics, Inc. Business Overview
Table 83. Innovent Biologics, Inc. PCSK9-targeted Therapy Product
Table 84. Innovent Biologics, Inc. Revenue in PCSK9-targeted Therapy Business (2020-2025) & (US$ Million)
Table 85. Innovent Biologics, Inc. Recent Development
Table 86. Akeso, Inc Company Details
Table 87. Akeso, Inc Business Overview
Table 88. Akeso, Inc PCSK9-targeted Therapy Product
Table 89. Akeso, Inc Revenue in PCSK9-targeted Therapy Business (2020-2025) & (US$ Million)
Table 90. Akeso, Inc Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
Table 94. Authors List of This Report
List of Figures
Figure 1. PCSK9-targeted Therapy Picture
Figure 2. Global PCSK9-targeted Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global PCSK9-targeted Therapy Market Share by Type: 2024 VS 2031
Figure 4. Subcutaneous Injection Features
Figure 5. Oral Features
Figure 6. Global PCSK9-targeted Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global PCSK9-targeted Therapy Market Share by Application: 2024 VS 2031
Figure 8. CVD Case Studies
Figure 9. Tumor Case Studies
Figure 10. Acne Case Studies
Figure 11. Others Case Studies
Figure 12. PCSK9-targeted Therapy Report Years Considered
Figure 13. Global PCSK9-targeted Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global PCSK9-targeted Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global PCSK9-targeted Therapy Market Share by Region: 2024 VS 2031
Figure 16. Global PCSK9-targeted Therapy Market Share by Players in 2024
Figure 17. Global Top PCSK9-targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCSK9-targeted Therapy as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by PCSK9-targeted Therapy Revenue in 2024
Figure 19. North America PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America PCSK9-targeted Therapy Market Share by Country (2020-2031)
Figure 21. United States PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe PCSK9-targeted Therapy Market Share by Country (2020-2031)
Figure 25. Germany PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific PCSK9-targeted Therapy Market Share by Region (2020-2031)
Figure 33. China PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America PCSK9-targeted Therapy Market Share by Country (2020-2031)
Figure 41. Mexico PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa PCSK9-targeted Therapy Market Share by Country (2020-2031)
Figure 45. Turkey PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE PCSK9-targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Novo Nordisk Revenue Growth Rate in PCSK9-targeted Therapy Business (2020-2025)
Figure 49. Sanofi Revenue Growth Rate in PCSK9-targeted Therapy Business (2020-2025)
Figure 50. Regeneron Revenue Growth Rate in PCSK9-targeted Therapy Business (2020-2025)
Figure 51. Amgen Revenue Growth Rate in PCSK9-targeted Therapy Business (2020-2025)
Figure 52. Novartis Revenue Growth Rate in PCSK9-targeted Therapy Business (2020-2025)
Figure 53. Hengrui Pharma Revenue Growth Rate in PCSK9-targeted Therapy Business (2020-2025)
Figure 54. TopAlliance Biosciences Revenue Growth Rate in PCSK9-targeted Therapy Business (2020-2025)
Figure 55. Innovent Biologics, Inc. Revenue Growth Rate in PCSK9-targeted Therapy Business (2020-2025)
Figure 56. Akeso, Inc Revenue Growth Rate in PCSK9-targeted Therapy Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
